Gainers
- Prenetics Global PRE stock increased by 7.9% to $5.18 during Friday's after-market session. The market value of their outstanding shares is at $63.2 million.
- Chromocell Therapeutics CHRO shares rose 5.39% to $0.67. The market value of their outstanding shares is at $3.8 million.
- Nuwellis NUWE shares rose 5.3% to $1.39. The company's market cap stands at $2.5 million.
- MiNK Therapeutics INKT stock moved upwards by 4.99% to $0.75. The market value of their outstanding shares is at $29.6 million.
- Accolade ACCD shares rose 4.8% to $3.93. The market value of their outstanding shares is at $314.4 million.
- Tharimmune THAR shares rose 4.76% to $2.2. The company's market cap stands at $2.5 million.
Losers
- Trevena TRVN shares fell 42.5% to $2.65 during Friday's after-market session. The market value of their outstanding shares is at $2.2 million.
- Entero Therapeutics ENTO shares declined by 16.63% to $0.5. The market value of their outstanding shares is at $1.6 million.
- NKGen Biotech NKGN shares fell 14.25% to $0.34. The market value of their outstanding shares is at $12.1 million.
- Kazia Therapeutics KZIA shares fell 10.12% to $0.4. The market value of their outstanding shares is at $11.9 million.
- Carmell CTCX shares declined by 9.63% to $0.36. The company's market cap stands at $7.4 million.
- Silexion Therapeutics SLXN stock fell 6.77% to $0.43. The company's market cap stands at $4.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CHROChannel Therapeutics Corp
$0.6122-4.34%
CTCXCarmell Corp
$0.396375.7%
ENTOEntero Therapeutics Inc
$0.6011-3.05%
INKTMiNK Therapeutics Inc
$0.550212.0%
KZIAKazia Therapeutics Ltd
$3.000.96%
NKGNNKGen Biotech Inc
$0.67945.69%
NUWENuwellis Inc
$1.125.66%
PREPrenetics Global Ltd
$5.59-1.14%
SLXNSilexion Therapeutics Corp
$2.706.79%
THARTharimmune Inc
$2.06-1.44%
TRVNTrevena Inc
$1.57-%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in